FCPM III Services B.V. Invests $65.63 Million in Damora Therapeutics Amid Significant Stock Surge
On March 31, 2026, FCPM III Services B.V. disclosed a new position of over 2.4 million shares in Damora Therapeutics (DMRA), valued at approximately $65.63 million based on quarterly average pricing. The investment represents nearly 8.75% of the fund's reportable assets under management as of that date, highlighting confidence amid DMRA’s stock surging by around 700% in a year.
Tickers: $GLTO
Topics: Damora Therapeutics FCPM III Services B.V. institutional investment SEC filing